All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Clinically oriented biomechanical analysis of acetabular fractures

Public support

  • Provider

    Ministry of Education, Youth and Sports

  • Programme

    KONTAKT

  • Call for proposals

    KONTAKT 6 (SMSM2008ME3)

  • Main participants

  • Contest type

    VS - Public tender

  • Contract ID

    7682/2010-32

Alternative language

  • Project name in Czech

    Klinicky orientována biomechanická analýza fraktur acetabula

  • Annotation in Czech

    Při operaci acetabulárních fraktur je prvotním cílem zachování anatomie kloubní jamky. Klinické studie ukazují, že incidence postraumatické artrózy je vyšší u pacientů s nekongruentní redukcí acetabulárního povrchu. Cílem projektu je vyvinout a ověřit matematický model, který by umožnil stanovení zátěže acetabula při posunutí kostního úlomku. Zátěž bude určena v průbehu chůze pro různé typy acebulární fraktury.

Scientific branches

  • R&D category

    ZV - Basic research

  • CEP classification - main branch

    BO - Biophysics

  • CEP - secondary branch

    FI - Traumatology and orthopaedics

  • CEP - another secondary branch

    EI - Biotechnology and bionics

  • OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)

    10610 - Biophysics<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30211 - Orthopaedics<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics

Completed project evaluation

  • Provider evaluation

    U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)

  • Project results evaluation

    Original method for complex simulation of acetabular fracure biomechanics was developed using the method DEA (discrete element analysis). Displacement of the acetabular fragment has been studied theoretically and applied in the clinical practice.

Solution timeline

  • Realization period - beginning

    Jan 1, 2009

  • Realization period - end

    Jan 31, 2010

  • Project status

    U - Finished project

  • Latest support payment

    Apr 15, 2010

Data delivery to CEP

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

  • Data delivery code

    CEP11-MSM-ME-U/01:1

  • Data delivery date

    Jun 30, 2011

Finance

  • Total approved costs

    160 thou. CZK

  • Public financial support

    160 thou. CZK

  • Other public sources

    0 thou. CZK

  • Non public and foreign sources

    0 thou. CZK